Methylenetetrahydrofolate reductase (MTHFR) genotype, smoking habit, metastasis and oral cancer in Taiwan

Anticancer Research

Volumn 31, Issue 6, 2011, Pages 2395-2399

  Tsai, Chia Wen ^a,b   Hsu, Chia Fang ^a,c   Tsai, Ming Hsui ^a   Tsou, Yung An ^a   Hua, Chun Hung ^a   Chang, Wen Shin ^a,b   Lin, Cheng Chieh ^a,b   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Chang Hua Hospital   (Taiwan)

Author keywords

Metastasis; Methylenetetrahydrofolate reductase MTHFR; Oral cancer; Recurrence; Smoking

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CIGARETTE SMOKING; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT; TAIWAN;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 79960443853     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Caplan DJ and Hertz-Picciotto I: Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent 58: 36-43, 1998. (Pubitemid 128657010)
2. Moore RJ, Doherty DA, Do KA, Chamberlain RM and Khuri FR: Racial disparity in survival of patients with squamous cell carcinoma of the oral cavity and pharynx. Ethn Health 6: 165-177, 2001. (Pubitemid 33000904)
3. Shiboski CH, Shiboski SC and Silverman S Jr.: Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol 28: 249-256, 2000.
4. Swango PA: Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 56: 309-318, 1996.
5. Department of Health, Taiwan: Cancer Registration System Annual Report. Taiwan, Department of Health, 2007.
6. Choi SW and Mason JB: Folate and carcinogenesis: an integrated scheme. J Nutr 130: 129-132, 2000.
7. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB and Ames BN: Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 94: 3290-3295, 1997.
8. Duthie SJ: Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull 55: 578-592, 1999.
9. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M and Bar-On H: A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 129: 1656-1661, 1999. (Pubitemid 29406617)
10. Parle-McDermott A, Mills JL, Molloy AM, Carroll N, Kirke PN, Cox C, Conley MR, Panilinan FJ, Brody LC and Scott JM: The MTHFR 1298CC and 677TT genotypes have opposite associations with red cell folate levels. Mol Genet Metab 88: 290-294, 2006. (Pubitemid 43977813)
11. Shi Q, Zhang Z, Li G, Pillow PC, Hernanadez LM, Spitz MR and Wei Q: Sex differences in risk of lung cancer associated with methylene-tetrahydrofolate reductase polymorphisms. Cancer Epidemiol Biomarkers Prev 14: 1477-1484, 2005. (Pubitemid 40807349)
12. Hornberger A, Linnebank M, Winter C, Willenbring H, Marquardt T, Harms E and Koch HG: Genomic structure and transcript variants of the human methylenetetrahydrofolate reductase gene. Eur J Hum Genet 8: 725-729, 2000.
13. Chen J, Giovannucci E, Hankinson SE, Ma J, Willett WC, Spiegelman D, Kesley KT and Hunter DJ: A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19: 2129-2132, 1998. (Pubitemid 29010251)
14. Sharp L, Little J, Schofield AC, Pavlidoub E, Cottona SC, Miedzybrodzkab Z, Bairda JOC, Haitesb NE, Heysc SD and Grubbd DA: Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett 181: 65-71, 2002. (Pubitemid 34310663)
15. Skibola CF, Smith MT, Kane E, Pavlidou E, Cotton SC, Miedzybrodzka Z, Baird JO, Haites NE, Heys SD and Grubb DA: Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96: 12810-12815, 1999. (Pubitemid 29513584)
16. Wiemels JL, Smith RN, Taylor GM, Eden OB, Alexander FE and Greaves MF: Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 98: 4004-4009, 2001.
17. Liu CS, Tsai CW, Hsia TC, Wang RF, Liu CJ, Hang LW, Chiang SY, Wang CH, Tsai RY, Lin CC and Bau DT: Interaction of methylenetetrahydrofolate reductase genotype and smoking habit in Taiwanese lung cancer patients. Cancer Genomics Proteomics 6: 25-329, 2009.
18. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuve LP and Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10: 111-113, 1995.
19. James SJ, Melnyk S, Pogribna M, Pogribny IP and Caudill MA. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J Nutr 132: 2361S-2366S, 2002.
20. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP and Blom HJ: A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62: 1044-1051, 1998.
21. Chang CH, Chang CL, Tsai CW, Wu HC, Chiu CF, Wang RF, Liu CS, Lin CC and Bau DT: Significant association of an XRCC4 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res 29: 1777-1782, 2009.
22. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, Lin CC and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902, 2008.
23. Chiu CF, Wang CH, Wang CL, Lin CC, Hsu NY, Weng JR and Bau DT: A novel single nucleotide polymorphism in XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
24. Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, Tsai MH and Bau DT: Association between DNA double-strand break gene Ku80 polymorphisms and oral cancer susceptibility. Oral Oncol 45: 789-793, 2009.
25. Hsiung DT, Marsit CJ, Houseman EA, Eddy K, McClean MD and Kelsey KT: Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16: 108-114, 2007. (Pubitemid 46174272)
26. Neumann AS, Lyons HJ, Shen H, Liu Z, Shi Q, Sturgis EM, Shete S, Spitz MR, El-Naggar A, Hong WK and Wei, Q: Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer 115: 131-136, 2005. (Pubitemid 40559678)
27. Kureshi N, Ghaffar S, Siddiqui S, Salahuddin I and Frossard PM: Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene. ORL J Otorhinolaryngol Relat Spec 66: 241-245, 2004. (Pubitemid 39664126)
28. Reljic A, Simundic AM, Topic E, Nikolac N, Justinic D and Stefanovic M: The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: the Croatian case-control study. Clin Biochem 40: 981-985, 2007. (Pubitemid 47301797)
29. Suzuki T, Matsuo K, Hiraki A, Saito T, Sato S, Yatabe Y, Mitsudomi T, Hida T, Ueda R and Tajima K: Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case-control study. Carcinogenesis 28: 1718-1725, 2007.
30. Hung RJ, Hashibe M, McKay J, Gaborieau V, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates I, Foretova L, Janout V, Bencko V, Chabrier A, Moullan N, Canzian F, Hall J, Boffetta P and Brennan P: Folate-related genes and the risk of tobacco-related cancers in Central Europe. Carcinogenesis 28: 1334-1340, 2007.
31. Vairaktaris E, Yapijakis C, Kessler P, Vylliotis A, Ries J, Wiltfang J, Vassiliou S, Derka S and Neukam FW: Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer. J Cancer Res Clin Oncol 132: 219-222, 2006. (Pubitemid 43144257)
32. Capaccio P, Ottaviani F, Cuccarini V, Cenzuales S, Cesana BM and Pignataro L: Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J Laryngol Otol 119: 371-376, 2005. (Pubitemid 40769336)
33. Weinstein SJ, Gridley G, Harty LC, Diehl SR, Brown LM, Winn DM, Bravo-Otero E and Hayes RB: Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 132: 762-767, 2002. (Pubitemid 34275079)